Metabolic characteristics of intracranial metastases, detected by single-voxel proton magnetic resonance spectroscopy, are seemingly not predictive for tumor response to gamma knife radiosurgery

Minimally Invasive Neurosurgery

Volumn 50, Issue 4, 2007, Pages 233-238

  Chernov, M ^a   Hayashi, M ^a   Izawa, M ^a   Nakaya, K ^a   Ono, Y ^a   Usukura, M ^a   Yoshida, S ^a   Kato, K ^a   Muragaki, Y ^a   Nakamura, R ^a   Iseki, H ^a   Hori, T ^a   Takakura, K ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Gamma knife radiosurgery; Metastatic brain tumor; Proton magnetic resonance spectroscopy; Response

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CLINICAL ARTICLE; COLON CANCER; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; INTRACRANIAL TUMOR; LUNG CANCER; MALE; METABOLIC PARAMETERS; PREDICTIVE VALIDITY; PREOPERATIVE EVALUATION; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION DOSE; RECTUM CANCER; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; TUMOR RECURRENCE;

AGED; BRAIN NEOPLASMS; CARCINOMA; ENERGY METABOLISM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTONS; RADIOSURGERY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 35949000964     PISSN: 09467211     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985891     Document Type: Article

References (35)

1. Graves EE, Nelson SJ, Vigneron DB, Chin C, Verhey L, MacDermott M, Larson D, Sneed PK, Chang S, Prados M, Lamborn K, Dillon W. A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 2000; 46: 319-328
2. Preul MC, Caramanos Z, Villemure JG, Shenouda G, LeBlanc R, Langleben A, Arnold D. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. Neurosurgery 2000; 46: 306-318
3. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 2002; 52: 1271-1276
4. Kuznetsov YE, Caramanos Z, Antel SB, Preul MC, Leblanc R, Villemure J-G, Pokrupa R, Olivier A, Sadikot A, Arnold DL. Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas. Neurosurgery 2003; 53: 565-576
5. Oh J, Henry RG, Pirzkall A, Lu Y, Li X, Catalaa I, Chang S, Dillon WP, Nelson SJ. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 2004; 19: 546-554
6. Sijens PE, Dijk P van, Oudkerk M. Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma. Magn Reson Med 1994; 32: 549-555
7. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR Biomed 1996; 9: 65-68
8. Chernov MF, Hayashi M, Izawa M, Ono Y, Hon T. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile. Int J Clin Oncol 2006; 11: 375-384
9. 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin. Brain Tumor Pathol 2006; 23: 35-40
10. Moller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002; 44: 371-381
11. Chernov MF, Hayashi M, İzawa M, Usukura M, Yoshida S, Ono Y, Muragaki Y, Kubo O, Hori T, Takakura K. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases. Brain Tumor Pathol 2006; 23: 19-27
12. Mehta MP, Rozental JM, Levin AB, Mackie TR, Kubsad SS, Gehring MA, Kinsella TJ. Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 1992; 24: 619-625
13. Auchter RM, Lamond JP, Alexander III E, Buatti JM, Chappel R, Friedman WA, Kinsella TJ, Levin AB, Noves WR, Schultz CJ, Loeffler JS, Mehta MP. A multi-institutional outcome and prognostic factor analysis of radiosurgery for respectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996; 35: 27-35
14. Flickinger JC, Lunsford LD, Somaza S, Kondziolka D. Radiosurgery: its role in brain metastasis management. Neurosurg Clin N Am 1996; 7: 497-504
15. Shiau CY, Sneed PK, Shu HKG, Lamborn KR, MacDermott MW, Chang S, Nowak P, Petti PL, Smith V, Verhey U, Ho M, Park E, Wara WM, Gutin PH, Larson DA. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 1997; 37: 375-383
16. Feigi GC, Horstmann GA. Volumetric follow up of brain metastases: a useful method to evaluate treatment outcome and predict survival after gamma knife surgery? J Neurosurg 2006; 105 (Suppl): 91-98
17. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EJ, Hudgins WR, Weiner R, Harsh GR IV, Sneed PK, Larson DA. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994; 28: 797-802
18. Alexander III E, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995; 87: 34-40
19. Petrovich Z, Yu C, Giannotta SL, O'Day S, Apuzzo MU. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg 2002; 97 (Suppl 5): 499-506
20. Lutterbach J, Cyron D, Henne K, Ostertag CB. Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 2003; 52: 1066-1074
21. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2003; 57: 452-464
22. MacDermott M, Sneed PK. Radiosurgery in metastatic brain cancer. Neurosurgery 2005; 57 (Suppl 5): S45-S53
23. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005; 62: 1125-1132
24. Aoyama H, Shirato H, Togo M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006; 295: 2483-2491
25. Kim DG, Chung H-T, Gwak H-S, Paek SH, Jung H-W, Han DH. Gamma knife radiosurgery for brain metastases: prognostic factors for survival and local control. J Neurosurg 2000; 93 (Suppl 3) 23-29
26. Goodman KA, Sneed PK, MacDermott MW, Shiau C-Y, Lamborn KR, Chang S, Park E, Wara WM, Larson DA. Relationship between pattern of enhancement and local control of brain metastases after radiosurgery. Int J Radiat Oncol Biol Phys 2001; 50: 139-146
27. Chang EL, Selek U, Hassenbusch III SJ, Maor MH, Allen PK, Mahajan A, Sawaya R, Woo SY. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery 2005; 56: 936-945
28. Hasegawa T, Kondziolka D, Flickinger JC, Germanwala A, Lunsford LD. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 2003; 52: 1318-1326
29. Szeifert GT, Salmon I, David P, Devriendt D, De Smedt F, Rorive S, Brotchi J, Levivier M. Tumor control and growth in a patient with two cerebral metastases treated with the Leksell Gamma Knife. In: Kondziolka D (ed.), Radiosurgery Vol. 4 Basel: Karger 2002; 152-161
30. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 2006; 64: 898-903
31. Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH. Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 2006; 104: 907-912
32. Lassen U, Andersen P, Daugaard G, Hoim S, Jensen M, Svarer C, Poulsen HS, Paulson OB. Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomography. Clin Cancer Res 1998; 4: 2591-2597
33. 1HMR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med 1995; 33: 818-826
34. Ishimaru H, Morikawa M, Iwanaga S, Kaminogo M, Ochi M, Hayashi K. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur Radiol 2001; 11: 1784-1791
35. Young RJ, Sills AK, Brem S, Knopp EA. Neuroimaging of metastatic brain disease. Neurosurgery 2005; 57 (Suppl 5): S10-S23